The Sir Ganga Ram Hospital on Tuesday started administering monoclonal antibody cocktail (MAC) to coronavirus patients, the medical facility said in a statement.
The hospital is administering a combination of casirivimab and imdevimab to consenting patients with mild and moderate COVID-19 symptoms at high risk of developing serious illness, it added.
The MRP of one MAC dose for a patient is Rs 59,750, the statement said.
According to the Drug Controller General of India (DCGI), selection of patients will entail that they have Covid positive test report, mild to moderate Covid disease, are in the age group of 12 and above and weighing at least 40 kg, and are at high risk of COVID-19.
Dr DS Rana, Chairman (BOM), Sir Ganga Ram Hospital said, “As per the claims of the company Roche/ Cipla, we hope MAC will be a major factor in the fight against COVID-19 to prevent disease from progressing to further severity.”
(Cover: Representational / Credit – Getty Images)
Delhi High Court orders premature release of two rape convicts, citing arbitrary rejection of their…
Nearly 20,000 items were reported lost in Delhi Metro over two years, with 70 per…
Swaraj explores India's political history through art, photography, rare archives and popular visual culture at…
Rain lashed several parts of Delhi, with the IMD forecasting continued showers, thunderstorms and gusty…
A 30-year-old man was stabbed to death in Rohini after intervening in a dispute over…
Art Spectra brings together 24 artists exploring diverse themes, mediums and contemporary visual expressions at…
